$15.62
1.58% yesterday
NYSE, Jun 13, 10:10 pm CET
ISIN
US87911J1034
Symbol
HQH

Tekla Healthcare Investors Stock price

$15.62
+0.26 1.69% 1M
-1.35 7.96% 6M
-0.43 2.68% YTD
-1.49 8.71% 1Y
-4.89 23.83% 5Y
-18.65 54.42% 10Y
-1.42 8.35% 20Y
NYSE, Closing price Fri, Jun 13 2025
-0.25 1.58%
ISIN
US87911J1034
Symbol
HQH
Sector

Key metrics

Market capitalization $831.63m
Enterprise Value $831.63m
P/E (TTM) P/E ratio 4.57
EV/Sales (TTM) EV/Sales 77.22
P/S ratio (TTM) P/S ratio 77.22
P/B ratio (TTM) P/B ratio 0.77
Dividend yield 11.08%
Last dividend (FY25) $1.73
Revenue growth (TTM) Revenue growth 4.66%
Revenue (TTM) Revenue $10.77m
EBIT (operating result TTM) EBIT $-350.00k
EPS (TTM) EPS $3.42
Show more

Is Tekla Healthcare Investors a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Financial data from Tekla Healthcare Investors

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
11 11
5% 5%
100%
- Direct Costs 11 11
0% 0%
98%
0.20 0.20
180% 180%
2%
- Selling and Administrative Expenses 0.46 0.46
31% 31%
4%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -0.35 -0.35
70% 70%
-3%
Net Profit 185 185
229% 229%
1,718%

In millions USD.

Don't miss a Thing! We will send you all news about Tekla Healthcare Investors directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tekla Healthcare Investors Stock News

Positive
Seeking Alpha
24 days ago
I maintain my buy rating on HQH for its high 13.6% yield, strong dividend coverage, and efficient healthcare sector diversification. HQH trades at an 8% discount to NAV, offering an attractive entry point compared to peers, despite recent price declines. The fund is well-positioned to benefit from long-term healthcare sector growth, driven by rising spending and health-conscious trends.
Neutral
Seeking Alpha
24 days ago
HQH offers a compelling mix of high yield and growth exposure to healthcare, trading at a discount to NAV with recent outperformance versus benchmarks. The fund benefits from strong healthcare industry tailwinds—aging populations and innovation—while active management and share buybacks support narrowing the NAV discount. A robust 13.6% market yield and a fair value estimate 36% above current p...
Positive
Seeking Alpha
about one month ago
Berkshire Hathaway's portfolio of cash flow generators allows financial independence and opportunistic moves without financing dependencies. The "Income Method" aims to replicate Mr. Buffett's financial independence by prioritizing the generation of income streams from our personal portfolios. We discuss our top picks with yields of up to 15%.
More Tekla Healthcare Investors News

Company Profile

Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.

Head office United States
Founded 1986
Website www.abrdnhqh.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today